Application Nr Approved Date Route Status External Links
BLA103411 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Oncaspar Is An Asparagine Specific Enzyme Indicated As A Component Of A Multi-Agent Chemotherapeutic Regimen For Treatment Of Pediatric And Adult Patients With: First-Line Acute Lymphoblastic Leukemia ( 1.1 ) Acute Lymphoblastic Leukemia And Hypersensitivity To Asparaginase ( 1.2 ) 1.1 First-Line Acute Lymphoblastic Leukemia (All) Oncaspar® Is Indicated As A Component Of A Multi-Agent Chemotherapeutic Regimen For The First-Line Treatment Of Pediatric And Adult Patients With All. 1.2 Acute Lymphoblastic Leukemia And Hypersensitivity To Asparaginase Oncaspar Is Indicated As A Component Of A Multi-Agent Chemotherapeutic Regimen For The Treatment Of Pediatric And Adult Patients With All And Hypersensitivity To Native Forms Of L-Asparaginase.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pegaspargase

Comments